Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
Clinical Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Front Endocrinol (Lausanne). 2022 Sep 6;13:901385. doi: 10.3389/fendo.2022.901385. eCollection 2022.
To evaluate the combined predictive value of MRI criteria with the prolactin-volume-ratio (PVR) to differentiate prolactinoma from non-prolactinoma, in small sellar lesions with hyperprolactinemia.
Retrospective analysis of 55 patients with sellar lesions of ≤15 mm diameter on MRI and hyperprolactinemia of ≤150 ng/mL, surgically treated between 2003 and 2020 at the Medical University of Vienna, with a conclusive histopathological report. Serum prolactin levels, extent of pituitary stalk deviation, size and volume of the lesion were assessed. The PVR was calculated by dividing the preoperative prolactin level by tumor volume.
Our study population consisted of 39 patients (71%) with a prolactin-producing pituitary adenoma (group A), while 16 patients (29%) had another type of sellar lesion (group B). Patients in group A were significantly younger (p=0.012), had significantly higher prolactin levels at diagnosis (p<0.001) as well as smaller tumor volume (p=0.036) and lower degree of pituitary stalk deviation (p=0.009). The median PVR was significantly higher in group A (243 ng/mL per cm) than in group B (83 ng/mL per cm; p=0.002). Furthermore, the regression operating characteristics analysis revealed a PVR >100 ng/mL per cm to be predictive for distinguishing prolactin-producing lesions from other small sellar lesions.
In patients with small sellar lesions, Prolactin-Volume-Ratios >100 represents a possible predictive marker for the diagnosis of prolactin-producing pituitary adenomas.
评估 MRI 标准与泌乳素-体积比(PVR)联合对大泌乳素血症小鞍内病变的泌乳素瘤与非泌乳素瘤进行鉴别诊断的预测价值。
回顾性分析了 2003 年至 2020 年期间在维也纳医科大学接受手术治疗的 55 例直径≤15mm 的鞍内病变且泌乳素≤150ng/ml 的患者,所有患者均有明确的组织病理学报告。评估血清泌乳素水平、垂体柄偏移程度、病变大小和体积。通过术前泌乳素水平除以肿瘤体积计算 PVR。
我们的研究人群包括 39 例(71%)泌乳素分泌性垂体腺瘤患者(A 组)和 16 例(29%)其他鞍内病变患者(B 组)。A 组患者明显更年轻(p=0.012),诊断时的泌乳素水平明显更高(p<0.001),肿瘤体积更小(p=0.036),垂体柄偏移程度更低(p=0.009)。A 组的中位数 PVR 明显高于 B 组(243ng/ml/cm 比 83ng/ml/cm;p=0.002)。此外,回归操作特征分析显示,PVR>100ng/ml/cm 可用于鉴别泌乳素分泌性病变与其他小鞍内病变。
在小鞍内病变患者中,PVR>100 可能是诊断泌乳素分泌性垂体腺瘤的预测标志物。